Revolution Medicines director Lorence H. Kim disposes of 17,090 common shares worth USD 3.57 million

Reuters2026/09/10 21:53

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Director Lorence H. Kim disclosed sales of 17,090 Revolution Medicines common shares on Sep. 8, 2026.
Sales were executed through a trust at weighted average prices of USD 206.6 to USD 212.27.
The trust’s beneficial ownership fell to zero shares following the transactions.
Kim reported 1,191 common shares held directly following the filing.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Revolution Medicines Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-388156), on September 10, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Revolution Medicines director Lorence H. Kim disposes of 17,090 common shares worth USD 3.57 million

You may also like

Crypto prices